A Study of Lazertinib (JNJ-73841937) Tablet in Healthy Adult Participants

NCT05896683 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Lazertinib

Sponsor

Janssen Research & Development, LLC